Dynatronics Corporation Announces Positive Year-end Results

SALT LAKE CITY, Sept. 22 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced results for its fiscal fourth quarter and year ended June 30, 2010.

Net income for the quarter ended June 30, 2010, increased 54 percent to $70,955 ($.01 per common share), compared to $46,102 ($.00 per common share) for the quarter ended June 30, 2009. Net income for the year ended June 30, 2010, increased 310 percent to $423,977 ($.03 per common share) compared to $103,324 ($.01 per common share) for the prior year.

“The increase in annual profits is attributable to improved sales, particularly in sales of higher margin capital equipment,” stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. “We also enhanced our operating efficiencies by reducing labor and overhead costs as well as securing better pricing and terms from vendors.”

These results continue the trend of seven consecutive profitable quarters for the company. “Despite the difficult economic times of the past two years, we have not only returned to solid profitability, but have also improved our cash position significantly,” added Cullimore. “The combination of improved profitability, better management of receivables and inventory, and a $500,000 federal income tax refund allowed us to reduce borrowings on our operating line of credit during the fiscal year by approximately $1,834,000.”

“Our efforts to reduce expenses have been complemented by specific marketing strategies that resulted in the increase in sales reported for the fiscal year,” said Larry K. Beardall, executive vice president of the company. “With the broad line of products we now offer and a strong sales force that continues to grow, we are focusing our efforts on developing relationships with large chains of clinics and hospitals, national accounts and group purchasing organizations (GPOs) that buy primarily through negotiated contracts.”

Beardall notes that nationally, GPOs as a group purchase an estimated $400 million of products annually related to physical medicine. “We are excited to be tapping into this new market opportunity,” added Beardall. “In addition, with the recent launch of our new e-commerce website, we’re seeing a significant portion of our total orders being placed over the web. These online sales help drive down our transaction costs and help us become more efficient.”

“With all of these positive developments, we feel that we’re clearly headed in the right direction despite the general economic conditions. We believe we are well positioned to capitalize on our efforts of the past year and accelerate our trends toward greater profitability and growth,” concluded Cullimore.

Dynatronics has scheduled a conference call for investors on Wednesday, September 22, 2010, at 1:00 p.m. ET. Those wishing to participate should call (800) 698-6162 and use passcode 5687000.

A summary of the financial results as of June 30, 2010 and 2009 and for the three and twelve month periods follows:

Summary Selected Financial Data

Statement of Operations Highlights







Three Months Ended

Twelve Months Ended


June 30,

June 30,


2010

2009

2010

2009






Net sales

$7,943,432

$8,058,431

$32,962,392

$32,406,891

Cost of sales

4,919,839

5,001,599

20,316,818

19,996,436

Gross profit

3,023,593

3,056,832

12,645,574

12,410,455

SG&A expenses

2,582,652

2,694,843

10,641,795

10,755,712

R&D expenses

270,021

218,298

914,932

993,338

Other expenses, net

83,756

116,823

388,802

522,145

Net income before income taxes

87,164

26,868

700,045

139,260

Income tax provision (benefit)

16,209

(19,234)

276,068

35,936

Net income

$70,955

$46,102

$423,977

$103,324

Diluted income per common share

$0.01

$0.00

$0.03

$0.01

Balance Sheet Highlights





June 30,

June 30,


2010

2009

Cash

$383,756

$141,714

Accounts receivable

3,735,251

4,739,727

Inventories

5,766,800

6,199,251

Total current assets

10,609,813

12,003,068

Total assets

15,090,329

17,087,289




Accounts payable

1,404,022

1,795,520

Accrued expenses

462,641

446,327

Line of credit

2,768,492

4,602,651

Total current liabilities

5,686,280

7,785,881

Total liabilities

8,291,052

10,667,540

Total liabilities and equity

$15,090,329

$17,087,289

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company’s expectations and similar statements such as the statement regarding expectations for future growth in the company’s business and market share gains. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company’s products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company’s products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company’s SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2009.

SOURCE Dynatronics Corporation

MORE ON THIS TOPIC